Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07570355
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acupuncture, Moxibustion and MeridianNot Yet RecruitingNot Applicable
NCT07570355Not Yet Recruiting
Not Applicable
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acu...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07571902
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07571902Not Yet Recruiting
Not Applicable
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571109
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571109Not Yet Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569055
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Guangxi Medical UniversityRecruiting
NCT07569055Recruiting
—
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoie...First Affiliated Hospital...
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
Result Breakdown
Not yet recruiting16 (80%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 24 (20%)
Phase 12 (10%)
Phase 31 (5%)